Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S F Lanes

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Thorax|July 1, 1992
Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control studyS F Lanes, C Poole, A M Walker
Pharmacoepidemiology and Drug Safety|November 26, 2008
Baseline risk of gastrointestinal disorders among new users of meloxicam, ibuprofen, diclofenac, naproxen and indomethacinS F Lanes, L A Rodrígeuz, E Hwangg
Lancet (London, England)|April 14, 1990
Fenoterol and fatal asthmaC Poole, S F Lanes, A M Walker
Drug Safety|May 5, 1998
A meta-analysis to assess the incidence of adverse effects associated with the transdermal nicotine patchS Greenland, M H Satterfield, S F Lanes
American Journal of Respiratory and Critical Care Medicine|September 10, 1998
Risk of emergency care, hospitalization, and ICU stays for acute asthma among recipients of salmeterolS F Lanes, L L Lanza, C E Wentworth
Thorax|August 1, 2002
Respiratory medications and risk of asthma deathS F Lanes, L A García Rodríguez, C Huerta
American Journal of Obstetrics and Gynecology|March 1, 1992
Oral contraceptive type and functional ovarian cystsS F Lanes, B Birmann, A M Walker, et al.
Journal of Clinical Epidemiology|March 1, 1997
International trends in sales of inhaled fenoterol, all inhaled beta-agonists, and asthma mortality, 1970-1992S F Lanes, B Birmann, D Raiford, et al.
Thorax|November 1, 1996
Risk of severe life threatening asthma and beta agonist type: an example of confounding by severityJ E Garrett, S F Lanes, J Kolbe, et al.
American Journal of Obstetrics and Gynecology|May 1, 1986
Toxic shock syndrome, contraceptive methods, and vaginitisS F Lanes, C Poole, N A Dreyer, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Thorax|July 1, 1992
Prescribed fenoterol and death from asthma in New Zealand, 1981-7: a further case-control studyS F Lanes, C Poole, A M Walker
Pharmacoepidemiology and Drug Safety|November 26, 2008
Baseline risk of gastrointestinal disorders among new users of meloxicam, ibuprofen, diclofenac, naproxen and indomethacinS F Lanes, L A Rodrígeuz, E Hwangg
Lancet (London, England)|April 14, 1990
Fenoterol and fatal asthmaC Poole, S F Lanes, A M Walker
Drug Safety|May 5, 1998
A meta-analysis to assess the incidence of adverse effects associated with the transdermal nicotine patchS Greenland, M H Satterfield, S F Lanes
American Journal of Respiratory and Critical Care Medicine|September 10, 1998
Risk of emergency care, hospitalization, and ICU stays for acute asthma among recipients of salmeterolS F Lanes, L L Lanza, C E Wentworth
Thorax|August 1, 2002
Respiratory medications and risk of asthma deathS F Lanes, L A García Rodríguez, C Huerta
American Journal of Obstetrics and Gynecology|March 1, 1992
Oral contraceptive type and functional ovarian cystsS F Lanes, B Birmann, A M Walker, et al.
Journal of Clinical Epidemiology|March 1, 1997
International trends in sales of inhaled fenoterol, all inhaled beta-agonists, and asthma mortality, 1970-1992S F Lanes, B Birmann, D Raiford, et al.
Thorax|November 1, 1996
Risk of severe life threatening asthma and beta agonist type: an example of confounding by severityJ E Garrett, S F Lanes, J Kolbe, et al.
American Journal of Obstetrics and Gynecology|May 1, 1986
Toxic shock syndrome, contraceptive methods, and vaginitisS F Lanes, C Poole, N A Dreyer, et al.
Pageof 4